Bryn Mawr Trust CO Adaptive Biotechnologies Corp Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 1,450 shares of ADPT stock, worth $15,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,450
Previous 1,450
-0.0%
Holding current value
$15,138
Previous $10,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ADPT
# of Institutions
245Shares Held
152MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$313 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$137 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$116 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$69.3 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.49B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...